Smoldering Myeloma: What We Know and Where We're Going image

Smoldering Myeloma: What We Know and Where We're Going

Apr 22, 2024
05:00PM - 06:00PM EDT
Online Event
Overview

Dr. Diko Kazandjian and Research APRN Kellye Koubeck from Sylvester Comprehensive Center join our MGUS/Smoldering Myeloma Chapter to talk about what we know about smoldering myeloma and how clinical trials at Sylvester will help us learn more about the disease, possible treatments, and future outcomes.

Agenda
5:00 PM
Introductions
Marisol Garcia

Marisol introduces the agenda of the event and featured speakers Dr. Diko Kazandjian and Research APRN Kellye Koubeck.

5:05 PM
Presentation
Dr. Diko Kazandjian and Research APRN Kellye Koubeck

Our panelists will talk about smoldering myeloma information and clinical trials.

 

5:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Marisol Garcia

Marisol Garcia

Marisol es la manager de operaciones de eventos en la fundación de HealthTree. En conjunto con los Managers de educación trabajan para traer reuniones de diferentes temas de interés para los pacientes. Estudió ingeniería industrial y aprovecha sus conocimientos para hacer lo que le apasiona, coordinar eventos mientras enseña y ayuda a pacientes y sus familias. Su misión es hacer llegar nuestro programa a más gente, tanto en inglés como en español.
Healthtree contact Dickran Kazandjian, MD

Dickran Kazandjian, MD

Dr. Kazandjian’s clinical and translational research interests lie in the treatment of precursor plasma cell disorders including high risk smoldering multiple…

Dr. Kazandjian’s clinical and translational research interests lie in the treatment of precursor plasma cell disorders including high risk smoldering multiple myeloma and the role of immunotherapy in plasma cell dyscrasias. In addition, he is re-evaluating the role of autologous stem cell transplant (ASCT) in the era of highly efficacious novel-novel drugs, immunotherapy biologics, and cell-based therapies with the hypothesis that certain subsets of patients with myeloma may not benefit by default upfront ASCT.
Healthtree contact Kellye Koubek, MS, APRN, AGNP-C

Kellye Koubek, MS, APRN, AGNP-C

Kellye Koubek is an Advanced Practice Registered Nurse at the University of Miami’s Sylvester Comprehensive Cancer Center.  After graduating in 2011 with a Bachelor of Science in Nursing from Xavier University, Kellye Koubek gained valuable experience working as a registered nurse in various hospital platforms. She then pursued a Master of Science from Hunter College in New York City, graduating in 2021 from Hunter’s Adult-Gerontology Primary Care Nurse Practitioner program. Her commitment to advancing oncology research is underscored by her prior experience as a Clinical Trial Nurse at Memorial Sloan Kettering Cancer Center. Currently, Kellye serves as a Research Advanced Practice Nurse at the Sylvester Myeloma Institute, specializing in plasma cell disorders. Beyond her clinical duties, Kellye actively contributes to the advancement of medical science by serving as a sub-investigator for interventional clinical trials, playing a crucial role in the implementation and development of research trials, and facilitating the dissemination of clinical trial findings.